Page results
-
Critical care incorporates general adult intensive care, high-dependency, the Post-Anaesthetic Care Unit (PACU), critical care outreach and the Critical Care Follow-up Clinic.
-
This page explains how to hand express your colostrum. It is for mothers/birthing parents who will have a baby on the neonatal unit.
-
Whether to check appointment details, receive test results and clinic letters, or to complete pre-visit questions and checks to prepare for appointments, more and more patients activate MyCare UCLH each day.
-
This patient information explains what Aural (ear) microsuction is and what your alternatives are.
-
At University College Hospital education is provided for inpatients of school age on the paediatric floor (T11) and the adolescent floor (T12).
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
The cochlear implant programme was founded in 1982, and we were the first clinical cochlear implant programme in the UK. The team has been involved with the successful implantation of more than 2,000 patients, both adults and children, from all over the UK.
-
UCLH provides an audiological service for GPs who would like to refer patients for age related audiological assessments.
-
The snoring and sleep disorders clinic offers, out-patient consultation including flexible endoscopy to assess upper airway collapse. Multidisciplinary team involvement for planning treatment.
-
The specialist allergy and clinical immunology service deals with the diagnosis and management of allergies and related immune system disorders in adults.
File results
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust